Fundraising FoxPatient Square Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Apollo Therapeuticsapollotx.cominSep 2023 · $226.5M✓ verified
A portfolio biopharmaceutical company translating basic medical research breakthroughs from leading universities into novel therapeutic medicines.
BiotechDeep TechHealthtechMedical DevicesCambridge, GB
Richard Butt(Chief Scientific Officer)inSanjay Aggarwal(Chief Medical Officer)in
Co-investorsRock Springs CapitalAlbionVCMaxqUCL Technology FundIP Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.